Orthopediatrics (KIDS) Cash from Operations (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Orthopediatrics | 394.83 Mn | 346.02 Mn | 43.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -131.76% |
| Dec 31, 2025 | 1,881.07% |
| Sep 30, 2025 | 94.45% |
| Jun 30, 2025 | -151.73% |
| Mar 31, 2025 | -4.24% |
| Dec 31, 2024 | 61.21% |
| Sep 30, 2024 | -68.73% |
| Jun 30, 2024 | 8.94% |
| Mar 31, 2024 | 11.31% |
| Dec 31, 2023 | 12.99% |
| Sep 30, 2023 | -98.24% |
| Jun 30, 2023 | 32.32% |
| Mar 31, 2023 | -93.39% |
| Dec 31, 2022 | 44.85% |
| Sep 30, 2022 | 25.85% |
| Jun 30, 2022 | -94.66% |
| Mar 31, 2022 | -239.84% |
| Dec 31, 2021 | -31.80% |
| Sep 30, 2021 | 89.56% |
| Jun 30, 2021 | -368.72% |
| Mar 31, 2021 | -1,119.75% |
| Dec 31, 2020 | 95.72% |
| Sep 30, 2020 | 52.70% |
| Jun 30, 2020 | -11.43% |
| Mar 31, 2020 | -2.57% |
| Dec 31, 2019 | -1,480.89% |
| Sep 30, 2019 | 93.82% |
| Jun 30, 2019 | -100.03% |
| Mar 31, 2019 | -27.24% |
| Dec 31, 2018 | -130.80% |
| Sep 30, 2018 | 82.20% |
| Jun 30, 2018 | -31.93% |
| Mar 31, 2018 | -51.46% |
| Dec 31, 2017 | -1,077.35% |
| Sep 30, 2017 | 108.04% |
| Jun 30, 2017 | -84,480.00% |
| Mar 31, 2017 | -100.38% |